Olaparib 150mg Tablet
Description
Lynparza 150mg Tablet
8 tablets
Olaparib 150mg Tablet
Uses of Lynparza Tablet
Treatment of Breast cancer
Treatment of Ovarian cancer
Benefits of Lynparza Tablet
Treatment of Breast cancer
Lynparza 150mg Tablet provides a targeted treatment option that specifically attacks cancer cells while sparing most healthy cells. Clinical studies have shown that Lynparza 150mg Tablet can significantly reduce the risk of cancer progression or recurrence and improve survival rates. By specifically inhibiting the PARP enzyme in cancer cells, Lynparza 150mg Tablet helps to slow the spread of the disease, providing patients with a more effective and less toxic treatment option.
Treatment of Ovarian cancer
Lynparza 150mg Tablet helps prevent the cancer from worsening for a longer period. The medicine is effective in both newly diagnosed cases and in recurrent ovarian cancer, offering a maintenance therapy option that can delay the need for further chemotherapy. This targeted therapy can lead to better management of the disease with a more personalized approach, improving overall outcomes and quality of life for patients.
Side effects of Lynparza Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Lynparza
Nausea
Vomiting
Fatigue
Anemia (low number of red blood cells)
Diarrhea
Decreased blood cells (red cells, white cells, and platelets)
Taste change
Cough
Breathlessness
Indigestion
Abdominal pain
Loss of appetite
Headache
Decreased white blood cell count (neutrophils)
How to use Lynparza Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Lynparza 150mg Tablet may be taken with or without food.
How Lynparza Tablet works
Lynparza 150mg Tablet is an anticancer medication. It works by inhibiting the growth of select tumor cell lines in vitro and decrease tumor growth in both as monotherapy or following chemotherapy.